SCOPUS 정보 검색 플랫폼

Volumn 46, Issue 3, 2000, Pages 475-477

Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B

(5) Cuenca Estrella, M a Mellado, E a Diaz Guerra, T M a Monzon, A a Rodriguez Tudela, J L a

a INSTITUTO DE SALUD CARLOS III (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ECHINOCANDIN B DERIVATIVE; FLUCONAZOLE; GLUCOSE; ITRACONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA GUILLIERMONDII; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; DRUG POTENCY; FUNGUS CULTURE; FUNGUS IDENTIFICATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRAIN DIFFERENCE;

EID: 0033825590 PISSN: 03057453 EISSN: None Source Type: Journal
DOI: 10.1093/jac/46.3.475 Document Type: Article

Times cited : (55)

References (9)

1
- 0030896916
- In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents
- (1997) Antimicrobial Agents and Chemotherapy , vol.41 , pp. 763-766
- Pfaller, M.A.¹ Messer, S.A.² Coffman, S.³

2
- 0031943562
- In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743 792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi
- (1998) Diagnostic Microbiology and Infectious Diseases , vol.30 , pp. 251-255
- Pfaller, M.A.¹ Marco, F.² Messer, S.A.³ Jones, R.N.⁴

3
- 0030896919
- In vitro activity of a new semisynthetic echinocandin, LY303366 against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species
- (1997) Antimicrobial Agents and Chemotherapy , vol.41 , pp. 863-865
- Zhanel, G.G.¹ Karlowsky, J.A.² Harding, G.A.³ Balko, T.V.⁴ Zelenitsky, S.A.⁵ Friesen, M.⁶

4
- 0031689491
- Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts
- (1998) Journal of Clinical Microbiology , vol.36 , pp. 2950-2956
- Espinel-Ingroff, A.¹

5
- 0345201630
- In vitro activity of voriconazole (UK-109 496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients
- (1999) Journal of Anti-microbial Chemotherapy , vol.44 , pp. 697-700
- Chavez, M.¹ Bernal, S.² Valverde, A.³ Gutierrez, M.J.⁴ Quindos, G.⁵ Mazuelos, E.M.⁶

6
- 0032824392
- Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits
- (1999) Antimicrobial Agents and Chemotherapy , vol.43 , pp. 2148-2155
- Petraitiene, R.¹ Petraitis, V.² Groll, A.H.³ Candelario, M.⁴ Sein, T.⁵ Bell, A.⁶

7
- 0008076520
- National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M27-A. NCCLS, Villanova, PA.
- (1997)

8
- 0027958512
- Improved medium for fluconazole susceptibility testing of Candida albicans
- (1994) Antimicrobial Agents and Chemotherapy , vol.38 , pp. 45-48
- Rodriguez-Tudela, J.L.¹ Martinez-Suarez, J.V.²

9
- 0029152794
- Correlation of in-vitro susceptibility test results with clinical response: A study of azole therapy in AIDS patients
- (1995) Journal of Antimicrobial Chemotherapy , vol.35 , pp. 793-804
- Rodriguez-Tudela, J.L.¹ Martinez-Suarez, J.V.² Dronda, F.³ Laguna, F.⁴ Chaves, F.⁵ Valencia, E.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.